Identifying the business/technology issues and solutions for making clinical genomics standard of care – with a call to action
Call to Action #4 – Technology companies building advanced genomic capabilities Tech products should clearly show their genomic capabilities and advance their integration of genomic
Call to Action #3 – Insurance company coverage information Genetic testing costs have decreased substantially, which should eliminate payers having different policies for coverage and
Call to Action #2 – Medical specialty groups computable guidelines Medical specialty associations have scientifically developed clear guidelines for the use of clinical genomics in
Call to Action #1 – Health system communications on the genetic services they provide A major step in making clinical genomics standard of care is
The adoption of clinical genomics as standard of care has been slow. In this blog post, we will examine the major issues affecting clinical adoption and discuss what needs to happen next.
Take a moment to review the content and features of this blog that will provide you with a comprehensive understanding of the topic and allow you to participate and connect with the author and other readers.